Detalhe da pesquisa
1.
A phase 1 study of triple-targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF-mutated cancers.
Cancer
; 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38261444
2.
Adjuvant Therapy for Stage III Melanoma Without Immediate Completion Lymph Node Dissection.
Ann Surg Oncol
; 29(2): 806-815, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34537899
3.
Targeting wild-type TP53 using AMG 232 in combination with MAPK inhibition in Metastatic Melanoma; a phase 1 study.
Invest New Drugs
; 40(5): 1051-1065, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35635631
4.
PIVOT-12: a phase III study of adjuvant bempegaldesleukin plus nivolumab in resected stage III/IV melanoma at high risk for recurrence.
Future Oncol
; 18(8): 903-913, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35073733
5.
Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial.
Lancet Oncol
; 22(6): 848-857, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34000246
6.
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma.
N Engl J Med
; 379(4): 341-351, 2018 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29863979
7.
Melanoma Metastases to the Adrenal Gland Are Highly Resistant to Immune Checkpoint Inhibitors.
J Natl Compr Canc Netw
; 2021 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34348236
8.
Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial.
Lancet Oncol
; 21(2): 294-305, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31952975
9.
Impact of initial treatment and prognostic factors on postprogression survival in BRAF-mutated metastatic melanoma treated with dacarbazine or vemurafenib ± cobimetinib: a pooled analysis of four clinical trials.
J Transl Med
; 18(1): 294, 2020 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32746839
10.
Impact of depth of response on survival in patients treated with cobimetinib ± vemurafenib: pooled analysis of BRIM-2, BRIM-3, BRIM-7 and coBRIM.
Br J Cancer
; 121(7): 522-528, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31417188
11.
Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma.
Cancer Immunol Immunother
; 68(4): 609-618, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30721341
12.
A nomogram to predict node positivity in patients with thin melanomas helps inform shared patient decision making.
J Surg Oncol
; 120(7): 1276-1283, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31602665
13.
Phase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follow-up.
J Am Acad Dermatol
; 90(2): 414-418, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37839734
14.
A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanoma.
Invest New Drugs
; 36(1): 103-113, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29127533
15.
Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 16(6): 742-774, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29891526
16.
Immune checkpoint inhibitors and radiosurgery for newly diagnosed melanoma brain metastases.
J Neurooncol
; 140(1): 55-62, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29909499
17.
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial.
Lancet Oncol
; 17(10): 1374-1385, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27592805
18.
Basal Cell Skin Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 14(5): 574-97, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27160235
19.
The 12-month analysis from Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT): A phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinoma.
J Am Acad Dermatol
; 75(1): 113-125.e5, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27067394
20.
Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial.
Lancet Oncol
; 16(6): 716-28, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25981810